Breaking News

Saneca Pharma Invests in Small-Scale API Capabilities

Investment includes several smaller reactors for 1-30kg batches

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Contract development and manufacturing organization (CDMO) Saneca Pharma is investing heavily in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up. The Slovakia-based company is strengthening its infrastructure and expanding its suite of equipment within its five API production units to reinforce its expertise in opiate and synthetic drug development and production. This investment includes several smaller reactors that enable Saneca Pharma to n...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters